Does Potassium Phosphate Monobasic Potassium Phosphate Dibasic In Interact with Digoxin?
CDI records a contraindicated classification for Potassium Phosphate Monobasic Potassium Phosphate Dibasic In and Digoxin. The stored summary is: Concurrent use increases risk of severe and potentially fatal hyperkalemia. Avoid use; if unavoidable, closely monitor serum potassium concentrations. The mechanism involves additive potassium-increasing effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Contraindicated
- Digoxin Class
- Cardiac Glycoside
- Management
- Do not take together
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Additive potassium-increasing effect
What To Tell Your Doctor or Pharmacist
If you are taking Potassium Phosphate Monobasic Potassium Phosphate Dibasic In and your doctor is considering prescribing Digoxin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask about alternative medications that do not interact with your current regimen
- Ask how frequently you should be monitored while these are co-prescribed
- Never stop or change either medication without first consulting your healthcare provider